943b Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 TrialBrian G. Feagan, Aparna R. Parikh, P. J. Rutgeerts et al.|Gastroenterology|2012Cited by 43
943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SCW. Sandborn, P. J. Rutgeerts, Jewel Johanns et al.|Gastroenterology|2012Cited by 27